Five-Year Data Demonstrate InterStim(TM) Therapy Offers Sustained Long-Term Efficacy and Quality of Life Improvements for Overactive Bladder Patients

World News: . []

The InterStim System is the Only Proven, Long-Term Sacral Neuromodulation Solution for Overactive Active Bladder DUBLIN - July 17 2017 - Medtronic plc NYSE MDT today announced that the InterStimTM system, which provides sacra l neuro...

More news and information about Medtronic plc

Published By:

Thomson Reuters: 14:00 GMT Monday 17th July 2017

Published: .

Search for other references to "five" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers